Business

Butterfly Network Inc (NYSE: BFLY) Appoints Leaders to Drive Innovation Also Health Technology Solutions, and Sientra Inc (NASDAQ: SIEN) Announces Chief Financial Officer

Butterfly Network Inc (NYSE: BFLY) a creative digital health firm, announced that Dr. Anderi Stoica would join Butterfly as Chief Technology Officer and David Ramsey as Chief Information Officer. 

Dr. Stoica will lead the firm’s product development, information technology operations, and technology innovation in the recently created executive position.  

Chief Executive officer and President Todd Fruchterman said they are excited to welcome Dr. Stocia to their executive team. 

Also, Dr. Fruchterman adds that Dr. Stoica’s knowledge of software enterprise tech solutions, along with large cloud outlets, and his experience of complex, creative product development will be instrumental as to create a world-class strategy of solutions and products. Moreover, Stoica’s partnership with David Ramsey will assure that they proceed to develop and regulate in a manner that supports the firm’s mission to improve clinical practice and world health equity through the democratization of ultrasound.  

Moreover, Dr. Stoica was CTO at BioTelemetry, Inc, by providing leading cardiac monitoring and diagnostics, where he led the global tech product development operations, enterprise, product information technology, and manufacturing of product and distribution. Philips obtained bioTelemetry in 2021.   

Sientra Announcement of Chief Financial Officer Appointment

Sientra Inc (NASDAQ: SIEN) a medical aesthetics firm mainly focused on plastic surgeons, announced that Andy Schmidt was appointed chief financial officer. Mr. Schmidt will direct the firm’s financial operations. 

Ron Menezes, President, and CEO of Sientra, said that they (Sientra) are pleased to welcome a leader like Andy to their team. Andy’s experience with growth-oriented firms will be worthwhile as they work together to develop their market share and progress the craft of plastic surgery. Also, he adds they are advantageous to hold a strong finance team, and currently, a smooth evolution plan in place enables them to take the next step ahead in improving their breast products and their performance.  

Besides, Mr. Schmidt gave rise to a firm with over 20 years of financial leadership experience and successfully directed various firms’ financial M & A and market strategies.   

Leave a Comment

Your email address will not be published.

*